D

DiaMedica Therapeutics
D

DMAC

4.29000
USD
-0.11
(-2.50%)
مغلق
حجم التداول
2,316
الربح لكل سهم
0
العائد الربحي
0
P/E
-8
حجم السوق
183,388,199
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: DiaMedica Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.